Stay updated on Atezolizumab and Epacadostat Combination Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.

Latest updates to the Atezolizumab and Epacadostat Combination Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedLocations section added with state-level sites: Arizona, Connecticut, Massachusetts, New York, and Washington. The footer link to HHS Vulnerability Disclosure was removed and the revision updated from v3.3.2 to v3.3.3.SummaryDifference0.7%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2; this is a minor site-wide change that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page footer now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0. This is a minor site version update and does not affect the study information or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedThe government funding notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check66 days agoChange DetectedNo significant changes detected between the old and new screenshots; the page layout and core study details appear unchanged.SummaryDifference0.4%

- Check94 days agoChange DetectedUpgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.SummaryDifference4%

Stay in the know with updates to Atezolizumab and Epacadostat Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.